Home Podcasts NEJM Interviews
NEJM Interviews

NEJM Interviews

NEJM Group 939 Episodes Oct 7, 2026

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Episodes

NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity.
NEJM Interview: Sarah Schmitz on protections for people enrolled in trials of investigational agents for obesity. Oct 7, 2026 5:35 Sarah Schmitz is an obesity medicine specialist at Weill Cornell Medicine and an assistant attending physician at New York–Presbyterian Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.H. Schmitz. Beyond Percentage of Weight Lost — Protecting Participants in Obesity Trials. N Engl J Med 2026;395:1355-1357.
NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds.
NEJM Interview: Benjamin Scher on opioid litigation and governance systems for spending related funds. Sep 30, 2026 8:50 Benjamin Scher is a lecturer and postdoctoral research associate in the Global Health Program at Princeton University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. B.D. Scher and H.H. Howard. Opioid-Settlement Funds — Lessons from Tobacco. N Engl J Med 2026;395:1249-1251.
NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends.
NEJM Interview: Christopher Forrest on declines in the health of U.S. children and the role of communities in reversing those trends. Sep 23, 2026 13:16 Christopher Forrest is a professor of pediatrics and the director of the Applied Clinical Research Center at Children’s Hospital of Philadelphia. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C.B. Forrest and N. Halfon. Declining Child Health in the United States — Addressing the Developmental Ecosystem. N Engl J Med 2026;395:1147-1149.
NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory.
NEJM Interview: Dhruv Khullar on concerns about displacement of clinicians by artificial intelligence and counterarguments based on economic theory. Sep 16, 2026 9:23 Dhruv Khullar is an associate professor of population health sciences and of medicine at Weill Cornell Medical College. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D. Khullar. Artificial Intelligence and the Future of the Clinical Workforce. N Engl J Med 2026;395:1041-1043.
NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services.
NEJM Interview: Elizabeth Kaplan on changes to the U.S. Preventive Services Task Force and the importance of evidence-based recommendations for preventive services. Sep 9, 2026 11:35 Elizabeth Kaplan is a clinical instructor and the director of health care access at the Center for Health Law and Policy Innovation at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Kaplan and C. Shachar. The Future of the USPSTF and Evidence-Based Recommendations. N Engl J Med 2026;395:937-939.
NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion.
NEJM Interview: Elizabeth Tobin-Tyler on the legal argument that permitting telehealth access to mifepristone can abet reproductive coercion. Sep 2, 2026 11:53 Elizabeth Tobin-Tyler is a professor of health services, policy and practice at the Brown University School of Public Health and of family medicine and medical science at Warren Alpert Medical School of Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. E. Tobin-Tyler and G. Chalker. Telehealth Access to Mifepristone — Evaluating Reproductive-
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research.
NEJM Interview: Rebecca Haffajee on the rescheduling of medical marijuana products and its potential effect on research. Aug 19, 2026 13:08 Rebecca Haffajee is a professor in the Department of Health Policy and Management at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R.L. Haffajee, R.A. Mikos, and Z.D. Cooper. Marijuana Rescheduling — A Game Changer for Research? N Engl J Med 2026;395:729-731.
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement.
NEJM Interview: Eric Schneider on the limitations of pay-for-performance programs and alternative options to support quality improvement. Aug 12, 2026 8:55 Eric Schneider is an adjunct professor of health policy and management at the Harvard T.H. Chan School of Public Health and a member of the Journal’s Perspective Advisory Board. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Chernew and E.C. Schneider. Rethinking the Role of Pay for Performance in Federal Health Care Quality Programs. N Engl J Med 2026;3
NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness.
NEJM Interview: Jean Nachega on the importance of investment in equitable partnerships, community trust, and local scientific leadership for outbreak preparedness. Aug 5, 2026 11:14 Jean Nachega is a professor of infectious diseases and the director of the Biomedical Research Institute at Stellenbosch University and an associate professor at the University of Pittsburgh School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Zumla and Others. Ebola at 50 — Lessons for Outbreak Response and Preparedness. N Engl J Med
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health.
NEJM Interview: Jerry Avorn on the role of litigation in addressing product-related damage to health. Jul 29, 2026 14:12 Jerry Avorn is a professor of medicine at Harvard Medical School and the codirector of the Program on Regulation, Therapeutics, and Law at Harvard Medical School and Brigham and Women’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Avorn. Products That Pose Health Risks — Can Litigation Protect Us When Government Fails? N Engl J Med 2026;395:4
NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines.
NEJM Interview: Arnold Monto on the value and feasibility of various methods for evaluating the protection offered by vaccines. Jul 22, 2026 8:40 Arnold Monto is a professor emeritus of epidemiology and of public health and codirector of the Center for Respiratory Virus Research and Response at the University of Michigan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Monto and H.Y. Chu. The Best of Both Worlds — Using Clinical Trial and Observational Data to Evaluate Vac
NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care.
NEJM Interview: Yaara Zisman-Ilani on navigating the uncertainty surrounding medication management in autism care. Jul 15, 2026 8:05 Yaara Zisman-Ilani is an associate professor in the Department of Social and Behavioral Sciences at the Barnett College of Public Health and in the Department of Psychiatry and Behavioral Science at the Lewis Katz School of Medicine, both at Temple University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Zisman-Ilani and Others. Pharmacotherapeutic Dec

Recommended